Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The eukaryotic translation elongation factor 1 alpha-like 3 pseudogene (ENSG00000250956) is a segment of human DNA that is homologous to the functional eukaryotic translation elongation factor 1 alpha genes but contains alterations such as disrupted coding sequences, loss of regulatory elements, or frameshift mutations that prevent it from encoding a functional protein product[1][4][5]. Pseudogenes like this may have arisen by gene duplication or retrotransposition but are typically regarded as non-functional "genomic fossils" and are not expressed as active proteins in the cell[4][5]. Although in rare cases some pseudogenes can be transcribed, or may have subtle regulatory effects, there is no evidence that ENSG00000250956 plays any direct role in disease, signaling, or cellular functions[1][4][5]. The precise nomenclature and classification are dictated by sequence homology rather than biological activity. This pseudogene is not considered a therapeutic or diagnostic target and is largely of interest for genomic annotation rather than functional biology or pharmacology[1][4].
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha-like 3 pseudogene.